Current Roles

Employees:
72
Revenue:
$15M
About
Milestone Pharmaceuticals Inc. is a cardiovascular drug development company developing novel small molecule therapeutics for transient cardiovascular conditions. Milestone's lead product is a potent and short-acting nasally-delivered calcium channel antagonist for the episodic treatment of paroxysmal supraventricular tachycardia (PSVT). The company's lead product, etripamil (MSP-2017), is in phase 3.
Milestone Pharmaceuticals Address
1111 Dr.-Frederik-Philips Blvd
Charlotte, NC
United States
Milestone Pharmaceuticals Email
Milestone Pharmaceuticals Phone Numbers
514-336-0444

Past Companies

Milestone Pharmaceuticals, Inc.Vice President, CMC
Axsome Therapeutics, Inc.Executive Director, CMC and Pharmaceutical Development
Lundbeck NA Ltd. (Formerly Cheslea Therapeutics Inc.)Senior Director-Chemistry, Manufacturing and Controls (CMC)

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.